男女他汀类药物治疗的剂量滴定:一项基于人群的队列研究。
Uptitration of statin therapy in women and men: a population-based cohort study.
作者信息
Kiss Pauline, Uijl Alicia, Grobbee Diederick E, Hollander Monika, Smits Elisabeth, Sturkenboom Miriam C J M, Peters Sanne A E
机构信息
Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
Department of Cardiology, Amsterdam University Medical Centers, Amsterdam Cardiovascular Sciences, University of Amsterdam, Amsterdam, The Netherlands.
出版信息
Eur Heart J Qual Care Clin Outcomes. 2025 Apr 17. doi: 10.1093/ehjqcco/qcaf017.
AIMS
Statins are widely used for the prevention and management of cardiovascular disease (CVD). Women have been shown to be less likely to receive guideline-recommended dose of statins and reach target lipid levels. This study aims to examine sex differences in titration patterns of statin therapy and in the attainment of cholesterol targets in a Dutch healthcare setting.
METHODS
Data on statin dispensing was extracted from the PHARMO Data Network between 2011-2020. New-statin users with at least two recorded statin dispenses were included. Cox proportional hazards models were used to study the association between sex and time to first uptitration of intensity and Poisson regressions were used to estimate sex differences in the attainment of cholesterol targets within six and eighteen months after statin initiation.
RESULTS
We identified 68 150 new users of statin therapy (46% women) with a median age of 65 years [Q1-Q3: 57-72]. The cumulative incidence of uptitration after three years of follow-up was 10% in women and 12% in men. After adjustment for age, CVD and other individual characteristics, women were 28% less likely to be uptitrated compared to men (adjusted HR for women vs men 0.72 (95%CI 0.69-0.75)). The adjusted RR of achieving cholesterol target levels within six and eighteen months after statin initiation in women vs men were 0.95 (95%CI 0.93-0.97) and 0.98 (95%CI 0.97-0.99).
CONCLUSION
Among new statin users, women are less likely to be uptitrated compared to men and to achieve cholesterol target levels.
目的
他汀类药物广泛用于心血管疾病(CVD)的预防和管理。研究表明,女性接受指南推荐剂量他汀类药物并达到目标血脂水平的可能性较小。本研究旨在探讨荷兰医疗环境中他汀类药物治疗滴定模式和胆固醇目标达成情况的性别差异。
方法
从2011年至2020年的PHARMO数据网络中提取他汀类药物配药数据。纳入至少有两次他汀类药物配药记录的新使用者。采用Cox比例风险模型研究性别与首次强度上调时间之间的关联,并采用Poisson回归估计他汀类药物起始后6个月和18个月内胆固醇目标达成情况的性别差异。
结果
我们确定了68150名他汀类药物治疗新使用者(46%为女性),中位年龄为65岁[第一四分位数-第三四分位数:57-72岁]。随访三年后,女性上调剂量的累积发生率为10%,男性为12%。在调整年龄、心血管疾病和其他个体特征后,与男性相比,女性上调剂量的可能性降低了28%(女性与男性的调整后风险比为0.72(95%置信区间0.69-0.75))。他汀类药物起始后6个月和18个月内女性与男性达到胆固醇目标水平的调整后风险比分别为0.95(95%置信区间0.93-0.97)和0.98(95%置信区间0.97-0.99)。
结论
在新的他汀类药物使用者中,与男性相比,女性上调剂量并达到胆固醇目标水平的可能性较小。